Fig. 3From: Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N-Trp53tm1Hw1 with TALEN-mediated Trp53 mutant geneCell viability of primary tumor cells to DOX. A-C After incubation of CT26, solid tumor cells and ascetic tumor cells with different concentrations of DOX for 24 h, the cell viability was determined by the MTT assay in triplicate. D The inhibitory concentration 50% (IC50) value is defined as the concentration of DOX that results in a 50% loss in cell viabilityBack to article page